James Pursley, an officer of Hinge Health, Inc., filed a Form 144 notice on November 20, 2026, disclosing a proposed sale of 50,000 shares of Hinge Health common stock on the NYSE.
Key Highlights
- Proposed sale: James Pursley, an officer of Hinge Health, Inc., intends to sell 50,000 shares of common stock with an aggregate market value of $5,405,000.00.
- Approximate sale date: The filing lists November 20, 2026 as the approximate date of sale, executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
- Shares outstanding: According to the filing, 68,485,043 shares of common stock were outstanding at the time of the notice.
- Source of shares: The shares proposed for sale were acquired as Restricted Stock Units (20,077 units, acquired November 18, 2025) and Performance Stock Units (29,923 units, acquired May 21, 2025), both from the issuer.
- 10b5-1 plan: The filing indicates the plan was adopted on June 12, 2026, and prior sales under the same plan totaled 33,000 shares on September 21, 2026 (gross proceeds $3,106,504.50) and 33,000 shares on August 21, 2026 (gross proceeds $2,905,663.20).
Pursley's Proposed Sale Under a 10b5-1 Plan at Hinge Health
According to the Form 144 filing, James Pursley, identified as an officer of Hinge Health, Inc. (NYSE:HNGE), submitted a notice of proposed sale of securities under Rule 144 of the Securities Act of 1933. The notice, dated November 20, 2026, covers 50,000 shares of Hinge Health common stock with an aggregate market value stated as $5,405,000.00. The broker identified for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
The filing discloses that the shares were acquired in two tranches directly from the issuer: 20,077 shares as Restricted Stock Units on November 18, 2025, and 29,923 shares as Performance Stock Units on May 21, 2025. Neither tranche was noted as a gift. The filing states that Pursley is relying on a Rule 10b5-1 trading plan adopted on June 12, 2026.
The filing also reports two prior sales under the same 10b5-1 plan within the past three months: 33,000 shares sold on September 21, 2026, generating gross proceeds of $3,106,504.50, and 33,000 shares sold on August 21, 2026, generating gross proceeds of $2,905,663.20. Both prior sales were attributed to Pursley at the same San Francisco address listed in the filing. Hinge Health's issuer address is listed as 455 Market Street, Suite 700, San Francisco, California 94105.
What Was Disclosed
Hinge Health officer James Pursley filed a Form 144 notice proposing to sell 50,000 shares of common stock on the NYSE on approximately November 20, 2026, under a 10b5-1 plan adopted June 12, 2026, with shares sourced from RSU and PSU awards from the issuer.



Please wait processing your request...